Alas, Steve <br/><br/>
Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Mar 2002 
 - 836-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols<br/>Apoptosis--drug effects<br/>Apoptotic Protease-Activating Factor 1<br/>Blotting, Western<br/>CASP8 and FADD-Like Apoptosis Regulating Protein<br/>Carrier Proteins<br/>Caspase Inhibitors<br/>Caspases--metabolism<br/>Cisplatin--pharmacology<br/>Combined Modality Therapy<br/>Cytochrome c Group--metabolism<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm<br/>Enzyme Activation--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Fas Ligand Protein<br/>Humans<br/>Intracellular Signaling Peptides and Proteins<br/>Lymphoma, AIDS-Related--metabolism<br/>Membrane Glycoproteins--metabolism<br/>Mitochondria--drug effects<br/>Proteins--metabolism<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Reactive Oxygen Species--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Rituximab<br/>Signal Transduction--drug effects<br/>Tumor Cells, Cultured--drug effects<br/>fas Receptor--metabolism